1435 related articles for article (PubMed ID: 9128304)
21. [Barrett's esophagus: endoscopic treatment of high-grade dysplasia and early cancer].
Bergman JJ; Marsman WA; Krishnadath KK; Fockens P; van Lanschot JJ; Tytgat GN
Ned Tijdschr Geneeskd; 2003 Nov; 147(46):2275-81. PubMed ID: 14655293
[TBL] [Abstract][Full Text] [Related]
22. Oesophagectomy remains the gold standard for treatment of high-grade dysplasia in Barrett's oesophagus.
Sujendran V; Sica G; Warren B; Maynard N
Eur J Cardiothorac Surg; 2005 Nov; 28(5):763-6. PubMed ID: 16188449
[TBL] [Abstract][Full Text] [Related]
23. Endoscopic resection for Barrett's esophagus with high-grade dysplasia or early esophageal adenocarcinoma.
Watson TJ
Semin Thorac Cardiovasc Surg; 2008; 20(4):310-9. PubMed ID: 19251170
[TBL] [Abstract][Full Text] [Related]
24. Barrett's esophagus: the role of laparoscopic fundoplication.
Abbas AE; Deschamps C; Cassivi SD; Allen MS; Nichols FC; Miller DL; Pairolero PC
Ann Thorac Surg; 2004 Feb; 77(2):393-6. PubMed ID: 14759403
[TBL] [Abstract][Full Text] [Related]
25. High-grade dysplasia in Barrett's oesophagus: natural history and review of clinical practice.
Thomas T; Richards CJ; de Caestecker JS; Robinson RJ
Aliment Pharmacol Ther; 2005 Mar; 21(6):747-55. PubMed ID: 15771761
[TBL] [Abstract][Full Text] [Related]
26. Is there an advantage to be gained from adding digital image cytometry of brush cytology to a standard biopsy protocol in patients with Barrett's esophagus?
Borovicka J; Schönegg R; Hell M; Kradolfer D; Bauerfeind P; Dorta G; Netzer P; Binek J; Meyenberger C; Fischer JE; Spieler P
Endoscopy; 2009 May; 41(5):409-14. PubMed ID: 19418394
[TBL] [Abstract][Full Text] [Related]
27. The development of dysplasia and adenocarcinoma during endoscopic surveillance of Barrett's esophagus.
Katz D; Rothstein R; Schned A; Dunn J; Seaver K; Antonioli D
Am J Gastroenterol; 1998 Apr; 93(4):536-41. PubMed ID: 9576444
[TBL] [Abstract][Full Text] [Related]
28. Advanced pathology under squamous epithelium on initial EMR specimens in patients with Barrett's esophagus and high-grade dysplasia or intramucosal carcinoma: implications for surveillance and endotherapy management.
Chennat J; Ross AS; Konda VJ; Lin S; Noffsinger A; Hart J; Waxman I
Gastrointest Endosc; 2009 Sep; 70(3):417-21. PubMed ID: 19555948
[TBL] [Abstract][Full Text] [Related]
29. A guide for surveillance of patients with Barrett's esophagus.
Provenzale D; Kemp JA; Arora S; Wong JB
Am J Gastroenterol; 1994 May; 89(5):670-80. PubMed ID: 8172136
[TBL] [Abstract][Full Text] [Related]
30. The Seattle protocol does not more reliably predict the detection of cancer at the time of esophagectomy than a less intensive surveillance protocol.
Kariv R; Plesec TP; Goldblum JR; Bronner M; Oldenburgh M; Rice TW; Falk GW
Clin Gastroenterol Hepatol; 2009 Jun; 7(6):653-8; quiz 606. PubMed ID: 19264576
[TBL] [Abstract][Full Text] [Related]
31. Treatment of Barrett's esophagus with high-grade dysplasia and intramucosal adenocarcinoma.
Zehetner J; DeMeester SR
Expert Rev Gastroenterol Hepatol; 2009 Oct; 3(5):493-8. PubMed ID: 19817671
[TBL] [Abstract][Full Text] [Related]
32. Dysplasia in Barrett's esophagus: limitations of current management strategies.
Spechler SJ
Am J Gastroenterol; 2005 Apr; 100(4):927-35. PubMed ID: 15784042
[TBL] [Abstract][Full Text] [Related]
33. Controversies in Barrett's esophagus: management of high grade dysplasia.
Sharma P
Semin Gastrointest Dis; 2001 Jan; 12(1):26-32. PubMed ID: 11215852
[TBL] [Abstract][Full Text] [Related]
34. Prospective evaluation of the prevalence of gastric Helicobacter pylori infection in patients with GERD, Barrett's esophagus, Barrett's dysplasia, and Barrett's adenocarcinoma.
Weston AP; Badr AS; Topalovski M; Cherian R; Dixon A; Hassanein RS
Am J Gastroenterol; 2000 Feb; 95(2):387-94. PubMed ID: 10685740
[TBL] [Abstract][Full Text] [Related]
35. Autofluorescence endoscopy in surveillance of Barrett's esophagus: a multicenter randomized trial on diagnostic efficacy.
Borovicka J; Fischer J; Neuweiler J; Netzer P; Gschossmann J; Ehmann T; Bauerfeind P; Dorta G; Zürcher U; Binek J; Meyenberger C
Endoscopy; 2006 Sep; 38(9):867-72. PubMed ID: 16981102
[TBL] [Abstract][Full Text] [Related]
36. [Surveillance of patients with Barrett's esophagus].
Endlicher E; Knüchel R; Messmann H
Z Gastroenterol; 2001 Aug; 39(8):593-600. PubMed ID: 11558064
[TBL] [Abstract][Full Text] [Related]
37. Prospective, controlled tandem endoscopy study of narrow band imaging for dysplasia detection in Barrett's Esophagus.
Wolfsen HC; Crook JE; Krishna M; Achem SR; Devault KR; Bouras EP; Loeb DS; Stark ME; Woodward TA; Hemminger LL; Cayer FK; Wallace MB
Gastroenterology; 2008 Jul; 135(1):24-31. PubMed ID: 18442484
[TBL] [Abstract][Full Text] [Related]
38. The incidence of adenocarcinoma and dysplasia in Barrett's esophagus: report on the Cleveland Clinic Barrett's Esophagus Registry.
O'Connor JB; Falk GW; Richter JE
Am J Gastroenterol; 1999 Aug; 94(8):2037-42. PubMed ID: 10445525
[TBL] [Abstract][Full Text] [Related]
39. Stepwise radical endoscopic resection for eradication of Barrett's oesophagus with early neoplasia in a cohort of 169 patients.
Pouw RE; Seewald S; Gondrie JJ; Deprez PH; Piessevaux H; Pohl H; Rösch T; Soehendra N; Bergman JJ
Gut; 2010 Sep; 59(9):1169-77. PubMed ID: 20525701
[TBL] [Abstract][Full Text] [Related]
40. Low prevalence of submucosal invasive carcinoma at esophagectomy for high-grade dysplasia or intramucosal adenocarcinoma in Barrett's esophagus: a 20-year experience.
Wang VS; Hornick JL; Sepulveda JA; Mauer R; Poneros JM
Gastrointest Endosc; 2009 Apr; 69(4):777-83. PubMed ID: 19136106
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
